Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-9-11
pubmed:abstractText
Gemcitabine is one of the key products actually used in metastatic breast cancer. Thanks to its favourable toxicity profile, gemcitabine can be used in combination with a number of drugs. Recently published and presented results from different trials may modify our perception and strategies regarding metastatic breast cancer. In this overview we will focus on the results of these trials and particularly those recent concerning the combination of gemcitabine with taxanes, vinorelbine, platinum salts and trastuzumab.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1769-6917
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
94 Spec No Actualites
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S90-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
[Updates on gemcitabine on metastatic breast cancer].
pubmed:affiliation
Service d'oncologie médicale, hôpital Tenon, Cancer Est. joseph.gligorov@tnn.aphp.fr
pubmed:publicationType
Journal Article, English Abstract, Review